There are currently 7 terms in this directory beginning with the letter B.
Benign prostatic hyperplasia (BPH)
A condition in which the prostate gland is enlarged and not cancerous.
Biochemical recurrence is a rise of prostate-specific antigen (PSA) levels in the blood of a prostate cancer patient after treatment with surgery or radiation. Biochemical recurrence may occur in patients who do not have symptoms. It may mean that the cancer has come back.
A measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
For a biopsy, the doctor takes out a small piece of tissue where the cancer seems to be. This tissue is checked for cancer cells. A core needle biopsy is often used to find prostate cancer.
An imaging test that gives important information about the bones, including the location of cancer that may have spread to the bones. It uses a small amount of radioactive contrast material (radioisotope) which is given through a vein. This material settles in areas of the bone to which the cancer may have spread. The radioactive substance can be seen in pictures as it collects in the problem areas ("hot spots").
A type of radiation therapy in which radioactive material sealed in seeds is placed directly into or near a tumor. Also called uranium seed implants, radiation brachytherapy, internal radiation therapy, and implant radiation therapy.
BRCA1 & BRCA2
A gene which, when damaged (mutated), puts a person at higher risk of developing breast, ovarian, prostate, and other types of cancer, compared to people who do not have the mutation.